ArticleBreast cancer (Dove Medical Press)2016

Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer.

Tineke Casneuf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.